These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35880656)

  • 1. SARS-CoV-2 IgG seropositivity after the severe Omicron wave of COVID-19 in Hong Kong.
    Poon RW; Chan BP; Chan WM; Fong CH; Zhang X; Lu L; Chen LL; Lam JY; Cheng VC; Wong SSY; Kok KH; Yuen KY; To KK
    Emerg Microbes Infect; 2022 Dec; 11(1):2116-2119. PubMed ID: 35880656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroprevalence of SARS-CoV-2 in Hong Kong and in residents evacuated from Hubei province, China: a multicohort study.
    To KK; Cheng VC; Cai JP; Chan KH; Chen LL; Wong LH; Choi CY; Fong CH; Ng AC; Lu L; Luo CT; Situ J; Chung TW; Wong SC; Kwan GS; Sridhar S; Chan JF; Fan CY; Chuang VWM; Kok KH; Hung IF; Yuen KY
    Lancet Microbe; 2020 Jul; 1(3):e111-e118. PubMed ID: 33230504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroprevalence of Unidentified SARS-CoV-2 Infection in Hong Kong During 3 Pandemic Waves.
    Boon SS; Wong MCS; Ng RWY; Leung DTM; Chen Z; Lai CKC; Ho WCS; Huang J; Wong BKC; Fung KSC; Chan PKS
    JAMA Netw Open; 2021 Nov; 4(11):e2132923. PubMed ID: 34779848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 infection- induced seroprevalence among children and associated risk factors during the pre- and omicron-dominant wave, from January 2021 through December 2022, Thailand: A longitudinal study.
    Suntronwong N; Vichaiwattana P; Klinfueng S; Puenpa J; Kanokudom S; Assawakosri S; Chansaenroj J; Srimuan D; Thatsanatorn T; Songtaisarana S; Sudhinaraset N; Wanlapakorn N; Poovorawan Y
    PLoS One; 2023; 18(4):e0279147. PubMed ID: 37104299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population Immunity and Covid-19 Severity with Omicron Variant in South Africa.
    Madhi SA; Kwatra G; Myers JE; Jassat W; Dhar N; Mukendi CK; Nana AJ; Blumberg L; Welch R; Ngorima-Mabhena N; Mutevedzi PC
    N Engl J Med; 2022 Apr; 386(14):1314-1326. PubMed ID: 35196424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of low population immunity to the severe Omicron BA.2 outbreak in Hong Kong.
    Chen LL; Abdullah SMU; Chan WM; Chan BP; Ip JD; Chu AW; Lu L; Zhang X; Zhao Y; Chuang VW; Au AK; Cheng VC; Sridhar S; Yuen KY; Hung IF; Chan KH; To KK
    Nat Commun; 2022 Jun; 13(1):3618. PubMed ID: 35750868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inferring Incidence of Unreported SARS-CoV-2 Infections Using Seroprevalence of Open Reading Frame 8 Antigen, Hong Kong.
    Zhao S; Mok CKP; Tang YS; Chen C; Sun Y; Chong KC; Hui DSC
    Emerg Infect Dis; 2024 Feb; 30(2):325-328. PubMed ID: 38167176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 seroprevalence among children in Greece during Omicron variant period.
    Dimopoulou D; Sotiri D; Kousi D; Loulou G; Raptaki K; Neofytou A; Dasoula F; Tampouratzi M; Koloi A; Eleftheriou E; Vergadi E; Papadimitriou E; Zorbadaki I; Mavridi A; Miliordos K; Steletou E; Strempela M; Fragkou PC; Spoulou V; Michos A; Gkentzi D; Papaevangelou V; Ladomenou F; Grivea I; Syrogiannopoulos G; Galanakis E; Zaoutis T; Tryfinopoulou K; Tsolia MN
    Eur J Pediatr; 2024 May; 183(5):2491-2499. PubMed ID: 38478132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal Randomized Cohort Study of SARS-CoV-2 Antibody Seroprevalence in the St. Petersburg Population.
    Smirnov VS; Lyalina LV; Milichkina AM; Khamitova IV; Zueva EV; Ivanov VA; Zaguzov VS; Totolian AA
    Viruses; 2022 Apr; 14(5):. PubMed ID: 35632653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating immunity to SARS-CoV-2 in nursing home residents using saliva IgG.
    Katz MJ; Heaney CD; Pisanic N; Smith L; Bigelow BF; Sheikh F; Boudreau A; Kruczynski K; Hsu YJ; Salinas AB; Cosgrove SE; Rock C
    J Am Geriatr Soc; 2022 Mar; 70(3):659-668. PubMed ID: 35038344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are SARS-CoV-2 Antibodies Detectable in Human Milk After Vaccination Against COVID-19?
    Scaggs Huang F
    J Pediatric Infect Dis Soc; 2022 Apr; 11(4):126. PubMed ID: 35394545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low Prevalence of SARS-CoV-2 Antibodies in Canine and Feline Serum Samples Collected during the COVID-19 Pandemic in Hong Kong and Korea.
    Go YY; Carrai M; Choi YR; Brackman CJ; Tam KWS; Law PYT; Woodhouse F; Gray J; Kim JH; Park J; Jeon CW; Jang H; Magouras I; Decaro N; Cheng SMS; Peiris M; Beatty JA; Barrs VR
    Viruses; 2023 Feb; 15(2):. PubMed ID: 36851796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimated SARS-CoV-2 infection rate and fatality risk in Gauteng Province, South Africa: a population-based seroepidemiological survey.
    Mutevedzi PC; Kawonga M; Kwatra G; Moultrie A; Baillie V; Mabena N; Mathibe MN; Rafuma MM; Maposa I; Abbott G; Hugo J; Ikalafeng B; Adelekan T; Lukhele M; Madhi SA
    Int J Epidemiol; 2022 May; 51(2):404-417. PubMed ID: 34718591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgG antibodies to SARS-CoV-2 in asymptomatic blood donors at two time points in Karachi.
    Hasan M; Moiz B; Qaiser S; Masood KI; Ghous Z; Hussain A; Ali N; Simas JP; Veldhoen M; Alves P; Abidi SH; Ghias K; Khan E; Hasan Z
    PLoS One; 2022; 17(8):e0271259. PubMed ID: 36001587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of Infections with SARS-CoV-2 Omicron BA.2 Variant, Hong Kong, January-March 2022.
    Mefsin YM; Chen D; Bond HS; Lin Y; Cheung JK; Wong JY; Ali ST; Lau EHY; Wu P; Leung GM; Cowling BJ
    Emerg Infect Dis; 2022 Sep; 28(9):1856-1858. PubMed ID: 35914518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Characteristics of SARS-CoV-2 Omicron infection in children imported from Hong Kong].
    Ma WJ; Wang XS; Tian H; Zhu YF; Wei ZQ; Xu J; Zhu QR; Zeng M
    Zhonghua Er Ke Za Zhi; 2022 Jun; 60(6):539-544. PubMed ID: 35658359
    [No Abstract]   [Full Text] [Related]  

  • 17. Changes in SARS-CoV-2 seroprevalence and population immunity in Finland, 2020-2022.
    Solastie A; Nieminen T; Ekström N; Nohynek H; Lehtonen L; Palmu AA; Melin M
    Emerg Microbes Infect; 2023 Dec; 12(2):2222849. PubMed ID: 37289188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroprevalence of SARS-CoV-2 anti-nucleocapsid total Ig, anti-RBD IgG antibodies, and infection in Thailand: a cross-sectional survey from October 2022 to January 2023.
    Chansaenroj J; Suntronwong N; Kanokudom S; Assawakosri S; Vichaiwattana P; Klinfueng S; Wongsrisang L; Thongmee T; Aeemjinda R; Khanarat N; Srimuan D; Thatsanathorn T; Yorsaeng R; Katanyutanon A; Thanasopon W; Bhunyakitikorn W; Sonthichai C; Angsuwatcharakorn P; Withaksabut W; Wanlapakorn N; Sudhinaraset N; Poovorawan Y
    Sci Rep; 2023 Sep; 13(1):15595. PubMed ID: 37730917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 seroprevalence in pregnant women during the first three COVID-19 waves in The Gambia.
    Janha RE; Bah A; Jah H; Touray F; Idris Y; Keita S; Gaye Y; Jallow S; Faye-Joof T; Njie B; Craik R; Mohammed NI; von Dadelszen P; D'Alessandro U; Roca A;
    Int J Infect Dis; 2023 Oct; 135():109-117. PubMed ID: 37586660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 RBD-specific and NP-specific antibody response of healthcare workers in the westernmost Austrian state Vorarlberg: a prospective cohort study.
    Atzl M; Muendlein A; Winder T; Fraunberger P; Brandtner EM; Geiger K; Klausberger M; Duerkop M; Sprenger L; Mutschlechner B; Volgger A; Benda M; Severgnini L; Jaeger JB; Drexel H; Lang A; Leiherer A
    BMJ Open; 2022 May; 12(5):e052130. PubMed ID: 35613821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.